Skip to main content

What the FDA labels say about taking them together

Clonazepam and phenobarbital

Clonazepam's FDA label of December 1, 2025 names phenobarbital in its drug interactions section; the phenobarbital labels PlainMeds reads (2) do not name clonazepam. The clonazepam label: “Cytochrome P-450 inducers, such as phenytoin, carbamazepine, lamotrigine, and phenobarbital induce clonazepam metabolism, causing an approximately 38% decrease in plasma clonazepam levels.”

Check it at the source: the clonazepam FDA label on DailyMed (effective December 1, 2025, H2-Pharma, LLC); the phenobarbital FDA label on DailyMed (effective August 27, 2026).

What does the clonazepam label say about phenobarbital?

Clonazepam label, drug interactions

Cytochrome P-450 inducers, such as phenytoin, carbamazepine, lamotrigine, and phenobarbital induce clonazepam metabolism, causing an approximately 38% decrease in plasma clonazepam levels.

Source: FDA drug label (Klonopin), NDA017533 (Cheplapharm), as published by H2-Pharma, LLC, effective December 1, 2025 (SPL set cfa0d79a-843c-4b88-95a1-e9511d649ca1), via openFDA; the full label on DailyMed

What does the phenobarbital label say about clonazepam?

Phenobarbital's label (effective August 27, 2026) and its 1 other brand-application label do not name clonazepam in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Phenobarbital), Chartwell RX, LLC, effective August 27, 2026 (SPL set 74428144-fb24-40a5-a670-3b876e2d116c), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

31Clonazepam generic labelers
0Phenobarbital generic labelers
ClonazepamPhenobarbital
Labeled forSeizures and epilepsy, AnxietySeizures and epilepsy
Boxed warningYesNo
Pharmacy cost (NADAC)$0.0244 per tablet 1 mg tablet$0.213 per tablet 100 mg tablet
Shortage nowIn shortageA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?